4.6 Article

Cardiovascular disease and mortality after a first episode of venous thromboembolism in young and middle-aged women

Journal

THROMBOSIS RESEARCH
Volume 138, Issue -, Pages 80-85

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.thromres.2015.11.039

Keywords

Cardiovascular disease; Cohort studies; Mortality; Venous thromboembolism; Women

Funding

  1. Janssen-Cilag
  2. Novartis
  3. Organon
  4. Schering
  5. Wyeth
  6. AFA
  7. Center for Gender Medicine KI
  8. Swedish Foundation Women and Health

Ask authors/readers for more resources

Background: Patients with a history of venous thromboembolism (VTE) seem to have an increased risk of arterial cardiovascular disease (CVD). Objectives: To evaluate the risk of CVD and overall mortality after a first episode of VTE in women and to assess common risk factors for VTE and CVD. Patients/methods: We performed a cohort study inviting 1433 women with a previous VTE (exposed) and 1402 women without VTE (unexposed). The cohort was derived from TEHS, a Swedish population-based case-control study on risk factors for VTE in women age 18-64 years. The women were recruited in 2002-2009. During 2011 information on CVD and mortality was obtained from a questionnaire and from the Swedish Patient Register and the Cause of Death Register. Hazard ratios (HR) for CVD and their 95% confidence intervals (CI) were calculated using Cox regression. In multivariate analyses we adjusted for age, smoking, diabetes mellitus, hypertension and body mass index. Results: 2108 (75%) women (mean age 47 +/- 13 years) accepted participation. During the total follow up of 11,920 person years 35 (3.2%, 95% CI 0.7-2.1) among the exposed and 14 (1.4%, 95% CI 0.2-4.3) among the unexposed had any CVD event. The adjusted HR for CVD was 2.0 (95% CI 1.1-3.9) the adjusted HR for mortality was 2.3 (95% CI 1.2-4.6) Conclusion: Women with a previous VTE had a two-fold increased risk of CVD and overall mortality. Adjusting for cardiovascular risk factors only modestly changed the estimates. (C) 2015 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Hematology

Xenotropic and polytropic retrovirus receptor 1 regulates procoagulant platelet polyphosphate

Reiner K. Mailer, Mikel Allende, Marco Heestermans, Michaela Schweizer, Carsten Deppermann, Maike Frye, Giordano Pula, Jacob Odeberg, Mathias Gelderblom, Stefan Rose-John, Albert Sickmann, Stefan Blankenberg, Tobias B. Huber, Christian Kubisch, Coen Maas, Stepan Gambaryan, Dmitri Firsov, Evi X. Stavrou, Lynn M. Butler, Thomas Renne

Summary: Polyphosphate, an inorganic polymer of linear-linked orthophosphate residues, plays a critical role in blood coagulation, with platelet XPR1 identified as a major regulator of polyphosphate metabolism. Pharmacological interference with XPR1 activity led to enhanced platelet-driven coagulation and thrombus formation via the polyphosphate/factor XII pathway. Deletion of Xpr1 in platelets resulted in polyphosphate accumulation, accelerated arterial thrombosis, and increased activated platelet-driven pulmonary embolism in mice. These findings highlight the importance of phosphate homeostasis in thrombosis.

BLOOD (2021)

Article Obstetrics & Gynecology

Use of sildenafil and other phosphodiesterase type 5 inhibitors among pregnant women in Scandinavia

Carolyn E. Cesta, Silvia Segovia Chacon, Anders Engeland, Anne Broe, Per Damkier, Kari Furu, Helle Kieler, Par Karlsson

Summary: In the Scandinavian countries over the last decades, few pregnant women used PDE5 inhibitors, with only a small proportion having a diagnosis of pulmonary arterial hypertension, suggesting off-label use in most cases. The majority of users were mothers over the age of 35. The safety of fetal exposure to sildenafil and other PDE5 inhibitors during pregnancy has not been established and further evaluation is needed as maternal age increases and additional uses are explored.

ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2021)

Article Multidisciplinary Sciences

An artificial neural network approach integrating plasma proteomics and genetic data identifies PLXNA4 as a new susceptibility locus for pulmonary embolism

Misbah Razzaq, Maria Jesus Iglesias, Manal Ibrahim-Kosta, Louisa Goumidi, Omar Soukarieh, Carole Proust, Maguelonne Roux, Pierre Suchon, Anne Boland, Delphine Daiain, Robert Olaso, Sebastian Havervall, Charlotte Thalin, Lynn Butler, Jean-Francois Deleuze, Jacob Odeberg, Pierre-Emmanuel Morange, David-Alexandre Tregouet

Summary: The study identified the new susceptibility gene PLXNA4 for PE through artificial neural networks and genome-wide association study, which was associated with worsened respiratory function in COVID-19 patients. The research effectively distinguished high-risk PE patients, providing new insights for the prevention and treatment of PE.

SCIENTIFIC REPORTS (2021)

Article Multidisciplinary Sciences

A single-cell type transcriptomics map of human tissues

Max Karlsson, Cheng Zhang, Loren Mear, Wen Zhong, Andreas Digre, Borbala Katona, Evelina Sjoestedt, Lynn Butler, Jacob Odeberg, Philip Dusart, Fredrik Edfors, Per Oksvold, Kalle von Feilitzen, Martin Zwahlen, Muhammad Arif, Ozlem Altay, Xiangyu Li, Mehmet Ozcan, Adil Mardonoglu, Linn Fagerberg, Jan Mulder, Yonglun Luo, Fredrik Ponten, Mathias Uhlen, Cecilia Lindskog

Summary: Advances in molecular profiling have enabled the creation of high-resolution single-cell type maps of human tissues, combining single-cell transcriptomics analysis with spatial antibody-based protein profiling. This technology allows researchers to explore the expression of human protein-coding genes and determine the number of elevated genes in different cell types, facilitating comparisons with bulk transcriptomics data. The analysis reveals distinct expression clusters corresponding to cell types with similar functions within and between organs.

SCIENCE ADVANCES (2021)

Article Hematology

Identification of Endothelial Proteins in Plasma Associated With Cardiovascular Risk Factors

Maria J. Iglesias, Larissa D. Kruse, Laura Sanchez-Rivera, Linnea Enge, Philip Dusart, Mun-Gwan Hong, Mathias Uhlen, Thomas Renne, Jochen M. Schwenk, Goran Bergstrom, Jacob Odeberg, Lynn M. Butler

Summary: This study identified 216 proteins associated with cardiovascular disease risk factor exposure, and showed a relationship between individual cardiovascular disease risk and corresponding biomarker profiles. The findings indicate that EC proteins in plasma could reflect vascular health status.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2021)

Article Multidisciplinary Sciences

Markers of neutrophil activation and neutrophil extracellular traps in diagnosing patients with acute venous thromboembolism: A feasibility study based on two VTE cohorts

Philip Smith, Axel Rosell, Maria Farm, Maria Bruzelius, Katherina Aguilera Gatica, Nigel Mackman, Jacob Odeberg, Charlotte Thalin

Summary: This study found the presence of neutrophil activation and NET formation in VTE patients using specific markers. However, adding NE or H3Cit-DNA to D-dimer did not improve the diagnostic accuracy compared to D-dimer alone. This study provides information on the feasibility of using markers of NETs as diagnostic tools in acute VTE, but suggests that their potential is limited in this setting.

PLOS ONE (2022)

Article Cell Biology

A human adipose tissue cell-type transcriptome atlas

Marthe Norreen-Thorsen, Eike Christopher Struck, Sofia Oling, Martin Zwahlen, Kalle Von Feilitzen, Jacob Odeberg, Cecilia Lindskog, Fredrik Ponten, Mathias Uhlen, Philip James Dusart, Lynn Marie Butler

Summary: This study profiles cell-type-enriched transcriptomes in human adipose tissue using bulk RNA-seq data, identifying over 2,300 cell-type-enriched transcripts and uncovering male-specific enriched genes. Additionally, the primary driver of variation between subcutaneous and visceral adipose tissue is found to be mesothelial cells.

CELL REPORTS (2022)

Article Genetics & Heredity

Testing for association with rare variants in the coding and non-coding genome: RAVA-FIRST, a new approach based on CADD deleteriousness score

Ozvan Bocher, Thomas E. Ludwig, Marie-Sophie Oglobinsky, Gaeelle Marenne, Jean-Francois Deleuze, Suryakant Suryakant, Jacob Odeberg, Pierre-Emmanuel Morange, David-Alexandre Tregoueet, Herve Perdry, Emmanuelle Genin

Summary: This study proposes a new strategy, RAVA-FIRST, for performing RVAT on WGS data. It consists of three steps and has been found to outperform other WGS-based RVAT methods. RAVA-FIRST enables investigations of rare non-coding variants in complex diseases and has been implemented in the R package Ravages.

PLOS GENETICS (2022)

Article Pharmacology & Pharmacy

Therapeutic potential of the Proprotein Convertase Subtilisin/Kexin family in vascular disease

Bianca E. Suur, Melody Chemaly, Moritz Lindquist Liljeqvist, Djordje Djordjevic, Markus Stenemo, Otto Bergman, Eva Karlof, Mariette Lengquist, Jacob Odeberg, Eva Hurt-Camejo, Per Eriksson, Daniel F. J. Ketelhuth, Joy Roy, Ulf Hedin, Michael Nyberg, Ljubica Matic

Summary: This study investigated the expression landscape and potential therapeutic targets of the PCSK family in cardiovascular disease. The results showed that PCSK6, PCSK5, PCSK7, and FURIN are potential therapeutic targets with differential expression patterns in plaques and aneurysms. The study provides insights into the role of PCSKs in cardiovascular diseases and potential new treatment options.

FRONTIERS IN PHARMACOLOGY (2022)

Article Public, Environmental & Occupational Health

Prenatal exposure to pregabalin, birth outcomes and neurodevelopment - a population-based cohort study in four Nordic countries

Elena Dudukina, Szimonetta Komjathine Szepligeti, Par Karlsson, Kofi Asomaning, Anne Kjersti Daltveit, Katja Hakkarainen, Fabian Hoti, Helle Kieler, Astrid Lunde, Ingvild Odsbu, Matti Rantanen, Johan Reutfors, Laura Saarelainen, Vera Ehrenstein, Gunnar Toft

Summary: This study investigated the association between prenatal exposure to pregabalin and the risks of adverse birth and postnatal neurodevelopmental outcomes. The findings suggest a possible link between prenatal pregabalin exposure and increased risk of stillbirth and major congenital malformations.

DRUG SAFETY (2023)

Article Multidisciplinary Sciences

Elevated plasma complement factor H related 5 protein is associated with venous thromboembolism

Maria Jesus Iglesias, Laura Sanchez-Rivera, Manal Ibrahim-Kosta, Clement Naudin, Gaelle Munsch, Louisa Goumidi, Maria Farm, Philip M. Smith, Florian Thibord, Julia Barbara Kral-Pointner, Mun-Gwan Hong, Pierre Suchon, Marine Germain, Waltraud Schrottmaier, Philip Dusart, Anne Boland, David Kotol, Fredrik Edfors, Mine Koprulu, Maik Pietzner, Claudia Langenberg, Scott M. Damrauer, Andrew D. Johnson, Derek M. Klarin, Nicholas L. Smith, David M. Smadja, Margareta Holmstrom, Maria Magnusson, Angela Silveira, Mathias Uhlen, Thomas Renne, Angel Martinez-Perez, Joseph Emmerich, Jean-Francois Deleuze, Jovan Antovic, Jose Manuel Soria Fernandez, Alice Assinger, Jochen M. Schwenk, Joan Carles Souto Andres, Pierre-Emmanuel Morange, Lynn Marie Butler, David-Alexandre Tregouet, Jacob Odeberg

Summary: This study uses proteomics profiling to screen plasma from patients with suspected acute VTE and multiple case-control studies to identify CFHR5 as a plasma biomarker associated with VTE. Higher levels of CFHR5 in plasma are associated with increased thrombin generation potential and platelet activation. GWAS analysis identifies six loci associated with CFHR5 plasma levels, but Mendelian randomization experiments do not establish causality between CFHR5 and VTE.

NATURE COMMUNICATIONS (2023)

Article Immunology

Targeting NETs using dual-active DNase1 variants

Hanna Englert, Josephine Goebel, Danika Khong, Maryam Omidi, Nina Wolska, Sandra Konrath, Maike Frye, Reiner K. Mailer, Manu Beerens, Julian C. Gerwers, Roger J. S. Preston, Jacob Odeberg, Lynn M. Butler, Coen Maas, Evi X. Stavrou, Tobias A. Fuchs, Thomas Renne

Summary: In this study, a dual-active DNase with DNase1 and DNase1L3 activities was engineered and its potential for degrading NETs was characterized in vitro. By transferring specific regions of DNase1L3 to DNase1, a dual-active DNase1 mutant with chromatin degrading activity was generated, which outperformed DNase1 and DNase1L3 in degrading dsDNA and chromatin, respectively. Transgenic mouse experiments confirmed the stability of the dual-active DNase1 mutant in circulation and its elimination via bile, suggesting its potential therapeutic application for thromboinflammatory diseases.

FRONTIERS IN IMMUNOLOGY (2023)

Article Biochemistry & Molecular Biology

Biliverdin Reductase B Is a Plasma Biomarker for Intraplaque Hemorrhage and a Predictor of Ischemic Stroke in Patients with Symptomatic Carotid Atherosclerosis

Melody Chemaly, David Marlevi, Maria-Jesus Iglesias, Mariette Lengquist, Malin Kronqvist, Daniel Bos, Dianne H. K. van Dam-Nolen, Anja van der Kolk, Jeroen Hendrikse, Mohamed Kassem, Ljubica Matic, Jacob Odeberg, Margreet R. de Vries, M. Eline Kooi, Ulf Hedin

Summary: This study explored the biomarker potential of plasma BLVRB, finding that it is associated with intraplaque hemorrhage (IPH) in carotid plaques and the risk of recurrent ischemic stroke. Additionally, the study demonstrated that plasma BLVRB levels can be used to monitor the efficacy of pharmacotherapy targeting IPH. These findings suggest that plasma BLVRB may serve as a biomarker for atherosclerotic plaque instability.

BIOMOLECULES (2023)

Meeting Abstract Hematology

Therapeutic Potential Of The Proprotein Convertase Subtilisin/Kexin ( PCSK) Family In Vascular Disease

Bianca E. Suur, Melody Chemaly, Moritz Lindquist Liljeqvist, Djordje Djordjevic, Markus Stenemo, Otto Bergman, Eva Karlof, Mariette Lengquist, Jacob Odeberg

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2022)

Article Hematology

Proteomics in thrombosis research

Fredrik Edfors, Maria Jesus Iglesias, Lynn M. Butler, Jacob Odeberg

Summary: This article explores the application of plasma proteomics in the research of venous thromboembolism. It discusses the potential for improving diagnostic and risk prediction tools through the identification of plasma proteins. The use of affinity and mass spectrometry-based methods allows for broad screening and identification of novel plasma biomarkers, and the article provides future perspectives on discovery strategies and emerging technologies.

RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2022)

Article Hematology

Adhesive properties of plasma-circulating and platelet-derived microvesicles from healthy individuals

E. O. Artemenko, S. I. Obydennyi, K. S. Troyanova, G. A. Novichkova, D. Y. Nechipurenko, M. A. Panteleev

Summary: In this study, we investigated the adhesive properties of circulating plasma-derived and platelet-derived microvesicles (MVs) and their potential role in thrombus growth. The results showed that both types of MVs weakly bound fibrinogen but did not stably adhere to immobilized fibrinogen. Moreover, the presence of these MVs did not significantly affect thrombus formation. Therefore, MVs present in the plasma of healthy individuals are unlikely to directly contribute to thrombus formation under arterial flow conditions.

THROMBOSIS RESEARCH (2024)

Letter Hematology

Recent monthly mortality for pulmonary embolism in the US

Giuseppe Lippi, Camilla Mattiuzzi, Emmanuel J. Favaloro

THROMBOSIS RESEARCH (2024)

Article Hematology

Exploration of rotational thromboelastometry (ROTEM) to characterize the coagulation profiles of newly diagnosed pediatric leukemia patients

Marium Malik, Maha Al-Ghafry, Abraham Haimed, Julia Su, Maribel Lema, Linda Shore-Lessersson, Suchitra S. Acharya

Summary: This study analyzed and evaluated leukemia-associated coagulopathy in newly diagnosed pediatric leukemia patients using CCTs and ROTEM. The results showed that fibrinogen and platelets played a significant role in causing coagulopathies in this population. This suggests the utility of using CCTs and ROTEM in the pediatric population to evaluate hemostatic function and guide blood product replacement.

THROMBOSIS RESEARCH (2024)

Review Hematology

Thrombotic triad in microgravity

Mohammad M. Elahi, Alexandra N. Witt, Edward L. G. Pryzdial, Paul B. McBeth

Summary: Thrombotic disease may be underdiagnosed in microgravity conditions, and the underlying factors are still poorly understood. A case of internal jugular vein thrombosis was recently diagnosed in a low-risk female astronaut, and six out of ten additional crew members showed risk factors for jugular venous flow. Observations in space and studies on Earth suggest that microgravity affects blood flow, coagulation, and vascular function.

THROMBOSIS RESEARCH (2024)

Review Hematology

Comparison of important factors to patients recovering from pulmonary embolism and items covered in patient-reported outcome measures: A mixed-methods systematic review

Stian Ingemann-Molden, Christina Krogner Caspersen, Nanna Rolving, Anette Arbjerg Hojen, Frederikus A. Klok, Erik L. Grove, Barbara Cristina Brocki, Jane Andreasen

Summary: This study found that no single PROM covered all aspects considered important by PE patients. PROMs recommended in the ICHOM core set covered most aspects, but worrisome thoughts, hypervigilance around symptoms, and uncertainty of illness were not covered.

THROMBOSIS RESEARCH (2024)

Article Hematology

Driver gene KRAS aggravates cancer-associated stroke outcomes

Haomin Yan, Tsutomu Sasaki, Yasufumi Gon, Kumiko Nishiyama, Hideaki Kanki, Hideki Mochizuki

Summary: The incidence of cancer-associated stroke has increased with the prolonged survival times of cancer patients. In this study, the researchers focused on the driver gene KRAS and found that KRAS mutations exacerbated neurological deficits after stroke and promoted tumor growth. They also identified the upregulation of pro-inflammatory responses and the promotion of STAT3 phosphorylation in mice with KRAS mutations. Additionally, the researchers found that colorectal cancer patients with stroke onset within 3 months after cancer diagnosis had a worse prognosis.

THROMBOSIS RESEARCH (2024)

Letter Hematology

Identification of two de novo variants causing inherited antithrombin deficiency by quantitative analysis of variant alleles

Tomoki Togashi, Satomi Nagaya, Makiko Meguro-Horike, Haruto Matsumoto, Yuta Imai, Koichi Yamaguchi, Yoshinari Fujii, Haruka Moriya, Yuika Kikuchi, Ibuki Yasuda, Shin-ichi Horike, Eriko Morishita

THROMBOSIS RESEARCH (2024)

Article Hematology

Shock score for prediction of clinical outcomes among stable patients with acute symptomatic pulmonary embolism

Marta Najarro, Winnifer Briceno, Carmen Rodriguez, Alfonso Muriel, Sara Gonzalez, Ana Castillo, Ignacio Jara, Parth Rali, Catalin Toma, Behnood Bikdeli, David Jimenez

Summary: The CPES score is a useful tool in identifying the risk of hemodynamic deterioration in normotensive patients with acute PE, with acceptable C-statistic, excellent specificity, and low positive predictive value.

THROMBOSIS RESEARCH (2024)

Article Hematology

Trimethylamine-N-oxide (TMAO) and basic fibroblast growth factor (bFGF) are possibly involved in corticosteroid resistance in adult patients with immune thrombocytopenia

Lei Liu, Huifang Xu, Jian Wang, Haiyan Wang, Saisai Ren, Qian Huang, Mingyan Zhang, Hui Zhou, Chunyan Yang, Lu Jia, Yu Huang, Hao Zhang, Yanling Tao, Ying Li, Yanan Min

Summary: This study investigated the gut microbiota metabolites and cytokines, chemokines, and growth factors in patients with ITP and found their association with treatment responsiveness. The findings suggest that imbalanced secretion of cyto(chemo)kins/growth factors and inadequate levels of TMAO are characteristic of patients with ITP.

THROMBOSIS RESEARCH (2024)

Article Hematology

Safety of fixed-dose heparin titration boluses in underweight patients

Roxanne Mcknight, Mohammad Salameh, Lee Ann Jones, Greta Anton, Lindsay Carter

Summary: This study evaluated the safety of fixed-dose heparin titration boluses in underweight patients with VTE. The results showed that although underweight patients required more frequent holding of heparin, there was no significant increase in bleeding risk.

THROMBOSIS RESEARCH (2024)